
Carvejohn 6.25 Tablet
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Carvedilol (6.25mg)
Overview Carvejohn 6.25 Tablet
Cardiovasin 6.25mg tablets effectively manage hypertension, angina pectoris, and congestive heart failure. This medication facilitates improved cardiac blood flow by promoting vasodilation. Consequently, it reduces the risk of future strokes and myocardial infarctions. Always take Cardiovasin 6.25mg with food, adhering strictly to your physician's prescribed dosage and regimen. Consistent use is crucial, even during periods of well-being or controlled blood pressure. Discontinuing this medication requires prior consultation with your doctor to avoid potential complications. Lifestyle adjustments, including regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as advised by your doctor), will enhance treatment efficacy. While generally well-tolerated, possible side effects may include lightheadedness, cephalalgia, dyspnea, and fatigue. Report any persistent or bothersome side effects to your doctor. Prior to commencing treatment, inform your physician of any pre-existing cardiac or renal conditions. Pregnant or lactating women should seek medical advice before initiating Cardiovasin 6.25mg therapy.
Uses of Carvejohn 6.25 Tablet
Managing elevated blood pressure | Addressing angina pectoris | Cardiac insufficiency treatment
Major Benefits of Carvejohn 6.25 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Carvejohn 6.25mg tablets should be administered with a meal.
Common Side effects of Carvejohn 6.25 Tablet:
- Decreased blood pressure
- Headache
- Fatigue
- Dizziness
- Breathlessness
How to use Carvejohn 6.25 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Carvejohn 6.25mg tablets should be administered with a meal.
How Carvejohn 6.25 Tablet works:
Carvejohn 6.25mg tablets combine alpha and beta-blocking actions. This dual mechanism reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Combining Carvejohn 6.25 Tablet and alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Use of Carvejohn 6.25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
Lactation compatibility for Carvejohn 6.25 mg tablets appears favorable. Available human data indicate minimal infant risk associated with maternal use.
DrivingUNSAFE
Taking Carvejohn 6.25 Tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving is inadvisable if these effects arise.
KidneySAFE IF PRESCRIBED
Carvejohn 6.25mg tablets are considered safe for use by individuals with kidney conditions; no dosage modification is typically necessary. Nevertheless, disclosure of any pre-existing kidney disease to your physician is advised. Routine blood pressure monitoring is suggested to guide any potential dosage changes.
LiverCAUTION
Patients with liver impairment should use Carvejohn 6.25mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Carvejohn 6.25mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Carvejohn 6.25 Tablet :
Should you forget a Carvejohn 6.25 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Carvejohn 6.25 Tablet
| Label | Value |
|---|---|
| Chemical Type | Carbazole-propanol derivative |
| Developing Good Habits | No. |
| Treatment Category | Heart |
| Action Class | Alpha-beta blocker |
